Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you for your fortitude and perseverance when it comes to ENZC, GF. You put in a lot of your precious time and have produced incredible DD for everyone to partake in as they responsibly see fit. I think a monkeypox monoclonal antibody eventually being produced by ENZC could be on the horizon but at this point you know better than I. Many thanks!
$ENZC
Thank you- I appreciate you sharing your wisdom in this field.
Since jhu vet school completed phase 1 containment tests meeting fda requirements as reported on rdgl blog, what if these containment results were than submitted already to fda by rdgl, to go along with the already fda submitted pre ide documents and the fda set the meeting up to go over the semantics of the human trials with the mayo clinic involved due to the ide approval being a foregone conclusion? Is that too much of a stretch of things or missing any steps?
That is one way to look at it but since it was JHU doctors and PET scan machines that did the work, it would be tough to fudge their containment numbers- as the numbers dont lie from PET scans and on the rdgl public blog has not been taken down as if JHU vet school disputed it. I doubt rdgl would want to start a dispute with jhu vet school right before fda ide submittal- that would be ludicrous.
Its not just MKs opinion, its the Mayo Clinics and JHU vet schools as well, based on their input and working with the FDA to meet the testing containment requirements the FDA has put forth to meet an IDE submittal- this has been reported on RDGL public blog page.
Results of PET scans have met FDA requirements through JHU vet school - further meetings would be going over the semantics of Thyroid testing by the Mayo Clinic as has been reported on the RDGL public blog page. Although ultimately needing approval by FDA, JHU vet school and Mayo Clinic are pretty good endorsers of moving forward at this point.
All good points, but not to be left out is the fact that JHU vet school doctors, using the PET scans as recommended by the FDA for IDE submittal purposes, has reported that containment through phase 1 rabbit testing has met the FDA guidelines for human trials and that has been publicly reported on and undisputed by JHU vet school through the RDGL blog page. I think this is a big go signal for some to buy in at current prices.
Probably some truth to your statements but in MKs defense maybe he was taking precautionary measures and waiting on the following for Mayo Clinic human trials: Mayo Clinic just bought (article published 2022) and was the first in North America to install and perform scans using Siemens Biograph Vision Quadra PET/CT system. These Quadra imaging systems were cleared by the FDA in March, 2021. This system is an order if magnitude more powerful than the Mayo Clinics prior best PET/CT scanner, allowing clinicians to observe organ to organ interaction.
https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-installs-1st-quadra-pet-ct-scanner-in-north-america/
The jhu vet school completed the PET scans and those results have now been reported to the public by RDGL, without any public dispute by the jhu vet school, that the fda containment requirements were met in phase 1 testing. The new 4th meeting on the docket could just be going over the specifics of the thyroid testing in human trials which would be the next Mayo Clinic involvement steps after containment results were shown as meeting fda requirements. Is that keeping it real?
Do you think there is a possibility the fda 4th meeting in April you have mentioned is about the specifics of any upcoming human trials? (under the auspices the fda already having approved of the IDE and it has not been reported yet to the public based on the jhu vet school PET scan containment results meeting the fda requirements and the fda having agreed to the rdgl updated semantics of the thyroid testing- seems as though those may just be formalities that can be reviewed online asynchronous at this point)
My take on it is that it is jhu vet schools machines and doctors doing the PET scans and outputting the results. Regardless of who directly hands the results to the fda those results come from jhu vet school.
The jhu vet school did the PET scans and would of directly created the PET scan reports on those results for the fda review not MK. MK would be a bystander on the those results and would not be able to report to the public and fda erroneous results and even if he could he would risk losing his life’s work if he did so. He is under contract and currently getting paid for this work so either way reporting erroneous results on a blog would be stupid at this point for him and his bank account when instead he could just not mention anything and carry on as usual.
The jhu vet school did the PET scans and gave their results to MK, so they would be on the hook with the fda as well if MK went ahead and reported erroneous containment results which dont match the jhu findings, no? Alternatively, if the fda containment results were not met after jhu vet school did the PET scans, MK and jhu vet school would have used their prior m.o. and not reported any PET scan news to the public- such as what you have mentioned many times they did with the polymer cook, no? (Ex they left out reporting to the public they were without a polymer cook for some time as you have mentioned)
Stumbling could be considered a form of momentum. The FDA wont readily approve of anything that they find to endanger a human. Phase 1 in the rabbit testing has proven containment already and phase 2 is just to see how low the dosage can be and still be effective- not to see if containment has been met as already proven in phase 1. Now it seems to be about the semantics involving the specifics of thyroid testing which the Mayo Clinic doctors can be involved to explain further. Do you not see it this way? The Mayo Clinic just got their Quattro PET scanner in June of last year and its the first one in North America.
https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-installs-1st-quadra-pet-ct-scanner-in-north-america/
Do you feel optimistic about upcoming April IDE meeting with the following statement RDGL put forth in their last written update needing to still be cleared up with the FDA? - “We concluded that we may have unintentionally confused the FDA with the wording of our Indication for Use for treating cancerous lymph nodes; so we clarified the semantics, which we will share with the FDA at our April meeting for their approval”
Can you check and have JHU post the RDGL PET scan containment findings through their website or on their blog themselves? Seems that would substantiate any containment claims made by RDGL meeting FDA requirements and allow JHU to promote their PET scans and be a part in a novel cancer finding.
Do you know where the new animal PET scans are being completed? If RDGL is using the new in house Mayo Clinic’s PET scan technology under their guidance, that may take some of the potential bs out of any situation as the Mayo Clinic would not cosign on RDGL using their equipment and than submitting erroneous results.
You must be keeping a close eye on that offering at .07 and what comes of it as a sign on how the company is doing one way or another?
What time frame are you expecting definitive news one way or another on the rabbit migration study and now the Mayo surrogate tissue study in order to meet FDA requirements for IDE? Seems like the company will want to 8k any good news on these right away considering the IDE hangs in the balance with their outcome and as well the stock price.
“And, yeah, where is that IsoPet treatment video? More smoke and mirrors from our inept CEO.”
Are you writing this statement because in your opinion you believe the RDGL social media rep is running roughshod over the doctor and their social media accounts? If so, are you looking for all news to be put in an 8k in order to not get bamboozled?
It does not seem as though the BOD is monitoring and supervising the rep that handles their social media accounts either, and you have alluded to that person as a flunkie in your past cynical post based on their sometimes unscrupulous claims
(ex. olive oil). Perhaps a BOD deep dive into that persons motives and actions are in order at this point?
Good objective questions SC8. I hope you and others are making yourselves useful to the board and writing the Doctor directly and letting him know your thoughts on these topics of interest. Not that it did any good but I wrote the moonshot program a while back letting them know about Vivos.
RDGL
Artificial Intelligence algorithms will be very helpful moving forward in the field of brachytherapy to reduce human error and enhance effectiveness and safety.
$rdgl
https://pubmed.ncbi.nlm.nih.gov/33914614/
https://pubmed.ncbi.nlm.nih.gov/34887152/
The simpleton approach is not working. I recommend you just provide the patent info kayak_wench discovered now to the Dr directly regardless of failing 5x over or not.
Thank you kayak_wench. Are you going to let the Dr know directly about these patent items your bringing up? I agree that the patent process failing 5x over signals a need for assistance. Im sure many on this board would appreciate it. Thank you ahead of time, if so.
(Fyi if still needed: press the home button and power button at the same time to create a screen shot on the iphone. If you have an android, press the power and volume down button for a screen shot.)
$rdgl
Seems to me the wench is more knowledgable and has seen more than the dr in the patent field. Kayak_wench got skills and knowledge that could be invaluable to the dr.
Although kayak_wench does not know how to do a screen shot from his cell phone does not make him a bad person. I for one believe he is telling the truth and appreciate the passing of great due diligence. Someone needs to get in the face of the Dr and let him know what kayak_wench found out so he can handle it and not leave it to someone else to drip the ball again for a fifth time.
Agreed. As well, the company placing a vivos website link online that the company knows it does not own does no good. If it is the same person that runs the website and twitter account, the person should be removed.
Relentless pursuit of cheapies
As for the EFS IDE process, to “market” the radiogel device is not to supply it for purchase as you stated but rather to simply move past the initial FDA EFS IDE approval process and on to human trials.
https://mdic.org/wp-content/uploads/2018/12/MDIC-EFS-Blueprint-for-EFS-Success-2016.pdf
“Ready for market implementation” in the context of the tweet imo implies FDA EFS IDE approval for human trials to take place not to the extent that human trials have started and completed.
Dully noted the words “ready for market implementation” used in the RDGL most recent tweet:
“Trusting the #cancermoonshot program will evaluate legitimate technologies that are ready for market implementation. #RadioGel™ is one such therapy that our partnering physicians are calling a #gamechanger in regards to invasive #tumor treatment.”
IMO the words “ready for market implementation. #RadioGel™ is one such therapy” implies FDA approval and human trials or “ready for market implementation” is not just happenstance anymore and that Radiogel has passed any pre approval EFS IDE process. Hopefully these words are not misleading. $RDGL
Good find Cameron12221. The link to the article on the website that goes over How To Increase Dosimetry Compliance Rates With Versant Physics Proven Management Process is a good read. RDGL could find some of this information helpful considering the FDA in December suggested RDGL focus on the details of their dosimetry calculations. Glad RDGL has Dr. Darrell Fisher, Vivos Inc’s medical physicist (and the author of the article) on board.
https://twitter.com/radiogel/status/1413978597040168962/photo/1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996238/
https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-Provides-2021-Recap-and-Outlines-2022-Objectives?id=340332
TenKay absolutely roasting (in some kind of way) and schooling this board. Company should start talking buyout soon or partnership with big Pharma based on science.
The mms may have another flush soon StockDetective. I will be waiting patiently in the 5s for those who need to dump it all- and get on with their life. Go for a hike. Good place to start for new investors is bid in the 5s. Penny stocks are not for everyone, especially if your older and need the money. Only invest what you can afford to lose. This is a long term investment. Go to radiogel.com, SEC, and otcmarkets websites to learn about the company and the milestones met. The focus of the company is ISOPET growth and FDA approval of EFS IDE and on to human trials. The ceo said in the last company update that rdgl has the funds needed to move forward through to fda efs ide approval and the CEO made an insider buy at .0795. The good samaritan on the board and Nut have excellent facts about the company and where it is headed.
$RDGL
Radiogel can be found through the fda ide process to be a very safe option for people with cancerous tumors to use and a medically effective cancer killing device for cancer patients- and which is easily administered by a trained doctor..the process will be covered by the patients insurance. $rdgl
“Radiogel™ is a hydrogel liquid containing tiny yttrium-90 phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.”
https://www.radiogel.com/
I concur- anything under .0795 (where the insider RDGL CEO Dr Korenko bought in) is cheap. $RDGL
Very encouraging- when the new hospital out of NY starts to use it and we hear any positive results from RDGL on it being used on more animals that will be helpful data to FDA for IDE approval. Tweets about its use and the imaging and micro injection technique not compromising any other in body structures would be amazing to hear. $RDGL
Looking forward to hearing more about the micro injection technique now being used. I do think the science expert and good samaritan on the board (Sca) has made some excellent points in “keeping it real” along with the Nut. Thankful to everyone using good links to back up information rather than just posting opinions all the time. $RDGL for the win!
Nice!